Re­gen­eron en­ters ven­ture in­vest­ing with $500M, poach­es se­nior part­ner from ARCH

Re­gen­eron, the 35-year-old drug­mak­er still led by its co-founders, is get­ting in­to the ven­ture in­vest­ing are­na.

The New York phar­ma will com­mit $100 mil­lion per …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.